Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)-1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010-2021)
- PMID: 37592824
- PMCID: PMC10681860
- DOI: 10.1093/infdis/jiad327
Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)-1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010-2021)
Abstract
Background: HIV poses significant challenges for vaccine development due to its high genetic mutation and recombination rates. Understanding the distribution of HIV subtypes (clades) across regions and populations is crucial. In this study, a systematic review of the past decade was conducted to characterize HIV-1/HIV-2 subtypes.
Methods: A comprehensive search was performed in PubMed, EMBASE, and CABI Global Health, yielding 454 studies from 91 countries.
Results: Globally, circulating recombinant forms (CRFs)/unique recombinant forms (URFs) accounted for 29% of HIV-1 strains, followed by subtype C (23%) and subtype A (17%). Among studies reporting subtype breakdowns in key populations, 62% of HIV infections among men who have sex with men (MSM) and 38% among people who inject drugs (PWIDs) were CRF/URFs. Latin America and the Caribbean exhibited a 25% increase in other CRFs (excluding CRF01_AE or CRF02_AG) prevalence between 2010-2015 and 2016-2021.
Conclusions: This review underscores the global distribution of HIV subtypes, with an increasing prevalence of CRFs and a lower prevalence of subtype C. Data on HIV-2 were limited. Understanding subtype diversity is crucial for vaccine development, which need to elicit immune responses capable of targeting various subtypes. Further research is needed to enhance our knowledge and address the challenges posed by HIV subtype diversity.
Keywords: HIV subtypes; HIV-1; HIV-2; epidemiology; prevalence.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. C. M., M. M., and V. O.-M. are current employees of Janssen (respectively, Janssen-Cilag Limited, Janssen-Cilag GmbH, and Janssen Vaccines & Prevention B.V.), all Johnson & Johnson companies, and they may own stock or stock options in that company. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
References
-
- UNAIDS Data 2021. Geneva: Joint United Nations Programme on HIV/AIDS; 2021. Licence: CC BY-NC-SA 3.0 IGO. https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_.... Accessed 05 March 2022.
-
- Fields BN, Knipe DM, Howley PM. Fields’ virology. 3rd ed. Philadelphia: Lippincott-Raven, 1996; 2:1881–952.
-
- Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends Mol Med 2012; 18:182–92. - PubMed
-
- Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS 2019;14:153–60. - PubMed
-
- Avert . HIV strains and types. https://www.avert.org/professionals/hiv-science/types-strains. Accessed 07 March 2022.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
